Cargando…
NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobioti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539288/ https://www.ncbi.nlm.nih.gov/pubmed/33028824 http://dx.doi.org/10.1038/s41392-020-00311-7 |
_version_ | 1783591029020033024 |
---|---|
author | Xie, Na Zhang, Lu Gao, Wei Huang, Canhua Huber, Peter Ernst Zhou, Xiaobo Li, Changlong Shen, Guobo Zou, Bingwen |
author_facet | Xie, Na Zhang, Lu Gao, Wei Huang, Canhua Huber, Peter Ernst Zhou, Xiaobo Li, Changlong Shen, Guobo Zou, Bingwen |
author_sort | Xie, Na |
collection | PubMed |
description | Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobiotics. These effects are mainly achieved by the driving effect of NAD(+) on metabolic pathways as enzyme cofactors transferring hydrogen in oxidation-reduction reactions. Besides, multiple NAD(+)-dependent enzymes are involved in physiology either by post-synthesis chemical modification of DNA, RNA and proteins, or releasing second messenger cyclic ADP-ribose (cADPR) and NAADP(+). Prolonged disequilibrium of NAD(+) metabolism disturbs the physiological functions, resulting in diseases including metabolic diseases, cancer, aging and neurodegeneration disorder. In this review, we summarize recent advances in our understanding of the molecular mechanisms of NAD(+)-regulated physiological responses to stresses, the contribution of NAD(+) deficiency to various diseases via manipulating cellular communication networks and the potential new avenues for therapeutic intervention. |
format | Online Article Text |
id | pubmed-7539288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75392882020-10-07 NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential Xie, Na Zhang, Lu Gao, Wei Huang, Canhua Huber, Peter Ernst Zhou, Xiaobo Li, Changlong Shen, Guobo Zou, Bingwen Signal Transduct Target Ther Review Article Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobiotics. These effects are mainly achieved by the driving effect of NAD(+) on metabolic pathways as enzyme cofactors transferring hydrogen in oxidation-reduction reactions. Besides, multiple NAD(+)-dependent enzymes are involved in physiology either by post-synthesis chemical modification of DNA, RNA and proteins, or releasing second messenger cyclic ADP-ribose (cADPR) and NAADP(+). Prolonged disequilibrium of NAD(+) metabolism disturbs the physiological functions, resulting in diseases including metabolic diseases, cancer, aging and neurodegeneration disorder. In this review, we summarize recent advances in our understanding of the molecular mechanisms of NAD(+)-regulated physiological responses to stresses, the contribution of NAD(+) deficiency to various diseases via manipulating cellular communication networks and the potential new avenues for therapeutic intervention. Nature Publishing Group UK 2020-10-07 /pmc/articles/PMC7539288/ /pubmed/33028824 http://dx.doi.org/10.1038/s41392-020-00311-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Xie, Na Zhang, Lu Gao, Wei Huang, Canhua Huber, Peter Ernst Zhou, Xiaobo Li, Changlong Shen, Guobo Zou, Bingwen NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title | NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title_full | NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title_fullStr | NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title_full_unstemmed | NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title_short | NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
title_sort | nad(+) metabolism: pathophysiologic mechanisms and therapeutic potential |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539288/ https://www.ncbi.nlm.nih.gov/pubmed/33028824 http://dx.doi.org/10.1038/s41392-020-00311-7 |
work_keys_str_mv | AT xiena nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT zhanglu nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT gaowei nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT huangcanhua nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT huberpeterernst nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT zhouxiaobo nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT lichanglong nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT shenguobo nadmetabolismpathophysiologicmechanismsandtherapeuticpotential AT zoubingwen nadmetabolismpathophysiologicmechanismsandtherapeuticpotential |